Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4771 AL 4785

Fall Frequency, Risk Factors, and Outcomes in Parkinson's Disease: A Cross-Sectional Analysis

Vizcarra JA, Hefter K, Lafontant DE, Duong MT, Ertefaie A, Litt B, Bassett DS, Siderowf A.

medRxiv [Preprint]. 2025 Sep 25:2025.08.05.25332959. doi: 10.1101/2025.08.05.25332959.

Mapping genetic effects on splicing in ten thousand post-mortem brain samples reveals novel mediators of neurological disease risk

Réal A, Bp K, Dredge WH, Muller BZ, Jang B, Tokolyi A, Won HH, Humphrey J, Raj T, Knowles DA.

medRxiv [Preprint]. 2025 Nov 10:2025.09.25.25336663. doi: 10.1101/2025.09.25.25336663.

Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's and Parkinson's disease using Polygenic Risk Scores and Mendelian Randomization

Chatterjee A, Alvarez B, Sharma RU, Jonson C, Wilkins HM, Pa J, Swerdlow RH, Goate A, Yaffe K, Andrews SJ.

medRxiv [Preprint]. 2025 Sep 27:2025.09.25.25336251. doi: 10.1101/2025.09.25.25336251.

Identification of Comprehensive Genetic Factors, Pathways, and Shared Genetic Architecture of Putamen Volume in Adolescent Cohort

Singh A, Posner J.

medRxiv [Preprint]. 2025 Sep 27:2025.09.24.25336566. doi: 10.1101/2025.09.24.25336566.

Orthogonal validation of PD Biomarkers: Multi-platform proteomics profiling of CSF, Plasma, and Urine confirms DDC as a consistent candidate

Kumar R, Beric A, Western D, Yang Z, Lin W, Timsina J, Cruchaga C, Ibanez L.

medRxiv [Preprint]. 2025 Sep 28:2025.09.25.25336658. doi: 10.1101/2025.09.25.25336658.

Living Alone Is Associated with Discontinuation of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease

Viljaharju V, Mertsalmi T, Pauls KAM, Koivu M, Eerola-Rautio J, Udd M, Pekkonen E.

Eur Neurol. 2025;88(5-6):159-166. doi: 10.1159/000548570. Epub 2025 Oct 3.

Parkinson's disease participant-led research: Towards neuroimaging-assisted deep brain stimulation programming

McAuley MD, Ionova AA, Horn A, Heming E, Onabajo CA, Solie MM, Stephenson SA, Boehnke SE.

J Parkinsons Dis. 2025 Dec;15(8):1535-1539. doi: 10.1177/1877718X251381454. Epub 2025 Oct 3.

Asperuloside: an emerging therapeutic candidate for Parkinson's disease through molecular mechanistic insights

Kushawaha SK, Vashisht K, Kumar H, Ashawat MS, Baldi A.

Inflammopharmacology. 2025 Nov;33(11):6389-6399. doi: 10.1007/s10787-025-01981-x. Epub 2025 Oct 3.

Cerebrospinal fluid biomarkers in early parkinsonism: Parsing disease from comorbidity

Messina C.

J Neurol Sci. 2025 Nov 15;478:123714. doi: 10.1016/j.jns.2025.123714. Epub 2025 Sep 29.

Prevalence, contributing factors, and clinical impact of apathy in Parkinson's disease

Gu L, Zhang P, Wang Y, Zhu Y, Li H, Shu H.

J Psychiatr Res. 2025 Nov;191:382-392. doi: 10.1016/j.jpsychires.2025.09.031. Epub 2025 Sep 20.

Dual SMAD inhibition as a versatile platform in human pluripotent stem cell-based regenerative medicine and disease modeling

Puspita L, Deline M, Shim JW.

Mol Cells. 2025 Nov;48(11):100284. doi: 10.1016/j.mocell.2025.100284. Epub 2025 Oct 3.

Modified Mediterranean diet effects on Parkinson's disease (MED-PARK): a single-centre randomised controlled trial protocol

Pirovano E, Marino F, Rossi E, Gennari A, Rasini E, Uslenghi M, Figueira I, Iacoviello L, Ferrari M, Cosentino M.

BMJ Open. 2025 Oct 5;15(10):e101946. doi: 10.1136/bmjopen-2025-101946.

Mogroside V: A Review of Its Structure, Synthesis, Pharmacokinetics, and Toxicity

Zhang T, Gao Z, Zeng D, Wang Y.

Arch Pharm (Weinheim). 2025 Oct;358(10):e70112. doi: 10.1002/ardp.70112.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias